Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crizotinib in c-MET Positive Gastric Adenocarcinoma
NCT02435108Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- May 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crizotinib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started May 2014; status: completed.
02
Drugs
crizotinib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT02435108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02435108.